Back to search

Reply to: ‘High prevalence of hepatitis C infection among multidrug-resistant tuberculosis patients’

Date:

05/15/2020

Citation:

Solomon SS, McFall AM, Lucas GM, Mehta SH. Reply to: 'High prevalence of hepatitis C infection among multidrug-resistant tuberculosis patients'. J Hepatol. 2020 May;72(5):1029-1030. doi: 10.1016/j.jhep.2020.01.020. Epub 2020 Feb 10. PMID: 32057917.

Abstract

No abstract available

View Full Research Publication

https://pubmed.ncbi.nlm.nih.gov/32057917/